{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:etakafusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03517176: Phase 1 Interventional Completed Pancreatic Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:Calpurbatug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03455972: Phase 1/Phase 2 Interventional Unknown status Safety and Efficacy
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:povetacicept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:elritercept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:cebsulfase alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN